Chronic kidney disease may increase risk of sudden cardiac arrest among Hispanic/Latino adults

Lead­ers on the Sen­ate Fi­nance Com­mit­tee are mak­ing a push to pass re­forms to phar­ma­cy ben­e­fit man­agers, which have had a tar­get on their backs

The car­dio­vas­cu­lar ben­e­fits of No­vo Nordisk’s block­buster weight loss drug We­govy are not de­pen­dent on the amount of weight pa­tients lost, ac­cord­ing to a new